Avalyn Pharma Inc.

Filing Date

Apr 29, 2026

Transaction Date

Apr 29, 2026

Accession Number

0001388325-26-000017

Form Type

3

Footnotes

1. (F1)The Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock and Series D Preferred Stock is convertible on a 1-for-19.2417 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.